TELETRADER News
8/4/2022, 10:04 PM
(Source: TeleTrader)
Amgen-0.65%
Amgen's Q2 EPS triples to $2.45
Amgen Inc. said on Thursday that its GAAP earnings per share (EPS) increased 202% year on year to $2.45 in the second trimester of fiscal 2022.
Total revenues were up 1% to $6.6 billion, while GAAP operating income came in at $2.2 billion, soaring 163% from the second quarter of 2021. GAAP net income jumped 184% to $1.32 billion.
The biopharmaceutical company's shares were flat in late trading after the release of the report.